Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma

Fig. 3

DLS size distribution histograms of (a) PHBV-PTX-NPs, (b) PDA-PHBV-PTX-NPs and (c) RGD-PDA-PHBV-PTX-NPs. The SEM images of (d) PHBV-PTX-NPs, (e) PDA-PHBV-PTX-NPs and (f) RGD-PDA-PHBV-PTX-NPs. The TEM images of (g) PHBV-PTX-NPs, (h, k) PDA-PHBV-PTX-NPs and (i, l) RGD-PDA-PHBV-PTX-NPs. (I) Zeta potential of samples data are expressed as means ± SD (n = 3). PHBV, ploy (3-hydroxybutyrate-co-3-hydroxyvalerate); PTX, paclitaxel; PDA, polydopamine; NPs, nanoparticles

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us